Costs of pulse versus continuous terbinafine for onychomycosis - 12/08/11
Supported by the Minneapolis Veterans Affairs Medical Center and its Health Services Research Center of Excellence for Chronic Disease Outcomes Research. Conflicts of interest: E. W. has conducted clinical trials and served as a consultant for several pharmaceutical companies which produce antifungal medications, including Dermik, Coloplast, Clay Park, Paddock, Novartis, and Barrier. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs. Reprints not available from the authors. |
Vol 56 - N° 3
P. 525-527 - mars 2007 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?